Literature DB >> 2438368

Human autoantibodies against a desmosomal protein complex with a calcium-sensitive epitope are characteristic of pemphigus foliaceus patients.

R W Eyre, J R Stanley.   

Abstract

Pemphigus foliaceus (PF) patients have antibodies against a tightly, but noncovalently bound complex of polypeptides, which consists of desmoglein I (DGI) and other, possibly desmosomal, proteins. Most PF antibodies bind a calcium-sensitive epitope on this complex and chelation of calcium destroys the reactivity of these sera with the complex, but not the complex itself. The PF sera that do bind the desmosomal complex in the absence of calcium are those sera capable of binding denatured DGI on immunoblotting, and these same sera also immunoprecipitate only DGI when the desmosomal complex is dissociated with SDS. These findings demonstrate that autoantibodies against a complex of desmosome-associated proteins are characteristic of PF and define a calcium-sensitive conformational epitope on this complex.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438368      PMCID: PMC2188354          DOI: 10.1084/jem.165.6.1719

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

Review 1.  Desmosomal proteins: new markers for identification and classification of tumors.

Authors:  R Moll; P Cowin; H P Kapprell; W W Franke
Journal:  Lab Invest       Date:  1986-01       Impact factor: 5.662

2.  Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies.

Authors:  J R Stanley; L Koulu; C Thivolet
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

3.  Identification and partial characterization of pemphigoid antigen extracted from normal human skin.

Authors:  J R Stanley; D T Woodley; S I Katz
Journal:  J Invest Dermatol       Date:  1984-01       Impact factor: 8.551

4.  Calcium regulation of cell-cell contact and differentiation of epidermal cells in culture. An ultrastructural study.

Authors:  H Hennings; K A Holbrook
Journal:  Exp Cell Res       Date:  1983-01       Impact factor: 3.905

5.  Human autoantibodies against desmosomes: possible causative factors in pemphigus.

Authors:  J C Jones; J Arnn; L A Staehelin; R D Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

6.  Immunological comparison of desmosomal components from several bovine tissues.

Authors:  G J Giudice; S M Cohen; N H Patel; M S Steinberg
Journal:  J Cell Biochem       Date:  1984       Impact factor: 4.429

7.  Identification of desmosomal surface components (desmocollins) and inhibition of desmosome formation by specific Fab'.

Authors:  P Cowin; D Mattey; D Garrod
Journal:  J Cell Sci       Date:  1984-08       Impact factor: 5.285

8.  Desmocalmin: a calmodulin-binding high molecular weight protein isolated from desmosomes.

Authors:  S Tsukita; S Tsukita
Journal:  J Cell Biol       Date:  1985-12       Impact factor: 10.539

9.  Intermediate filaments and the initiation of desmosome assembly.

Authors:  J C Jones; R D Goldman
Journal:  J Cell Biol       Date:  1985-08       Impact factor: 10.539

10.  Human autoantibodies against a desmosomal core protein in pemphigus foliaceus.

Authors:  L Koulu; A Kusumi; M S Steinberg; V Klaus-Kovtun; J R Stanley
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

View more
  32 in total

Review 1.  Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.

Authors:  J R Stanley
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

2.  HLA antigens and risk for development of pemphigus foliaceus (fogo selvagem) in endemic areas of Brazil.

Authors:  J R Moraes; M E Moraes; M Fernandez-Vina; L A Diaz; H Friedman; I T Campbell; R R Alvarez; S A Sampaio; E A Rivitti; P Stastny
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  Characterization of keratocalmin, a calmodulin-binding protein from human epidermis.

Authors:  J A Fairley; G A Scott; K D Jensen; L A Goldsmith; L A Diaz
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

4.  Antibodies to the desmoglein 1 precursor proprotein but not to the mature cell surface protein cloned from individuals without pemphigus.

Authors:  Jun Yamagami; Stephen Kacir; Ken Ishii; Aimee S Payne; Don L Siegel; John R Stanley
Journal:  J Immunol       Date:  2009-11-01       Impact factor: 5.422

5.  Pathogenic IgG4 autoantibodies from endemic pemphigus foliaceus recognize a desmoglein-1 conformational epitope.

Authors:  Flor Evangelista; Aleeza J Roth; Phillip Prisayanh; Brenda R Temple; Ning Li; Ye Qian; Donna A Culton; Zhi Liu; Oliver J Harrison; Julia Brasch; Barry Honig; Lawrence Shapiro; Luis A Diaz
Journal:  J Autoimmun       Date:  2018-01-04       Impact factor: 7.094

Review 6.  Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.

Authors:  Christoph M Hammers; John R Stanley
Journal:  Annu Rev Pathol       Date:  2016-02-22       Impact factor: 23.472

Review 7.  The tumor-suppressor function of E-cadherin.

Authors:  H Semb; G Christofori
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

8.  Divergent Specificity Development of IgG1 and IgG4 Autoantibodies in Endemic Pemphigus Foliaceus (Fogo Selvagem).

Authors:  Mike Maldonado; Luis A Diaz; Phillip Prisayanh; Jinsheng Yang; Bahjat F Qaqish; Valeria Aoki; Gunter Hans-Filho; Evandro A Rivitti; Donna A Culton; Ye Qian
Journal:  Immunohorizons       Date:  2017-08-01

9.  Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skin.

Authors:  Paula Berkowitz; Michael Chua; Zhi Liu; Luis A Diaz; David S Rubenstein
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

10.  Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic.

Authors:  M Amagai; S Karpati; R Prussick; V Klaus-Kovtun; J R Stanley
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.